News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
QIAGEN and GENEART AG Partner to Commercialize Synthetic Mammalian Genes
May 14, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
REGENSBURG, GERMANY--(Marketwire - May 14, 2008) - Complete set of mammalian genes is optimized & produced by GENEART and sold via QIAGEN's GeneGlobe web portal
Twitter
LinkedIn
Facebook
Email
Print
Alliances
Europe
MORE ON THIS TOPIC
Layoff Tracker
Galapagos Plans Cell Therapy Exit, Potentially Affecting 365 Employees
October 22, 2025
·
73 min read
·
BioSpace Editorial Staff
Antibody-drug conjugate (ADC)
Takeda Bets up to $11.4B for Three Innovent ADCs
October 22, 2025
·
2 min read
·
Tristan Manalac
C-suite
Novo Foundation Replaces Pharma’s Board, Revealing Deep Divisions Over Leadership
October 21, 2025
·
4 min read
·
Annalee Armstrong
Cell therapy
Galapagos Exits Cell Therapy, Cuts 365 Employees
October 21, 2025
·
2 min read
·
Tristan Manalac
